Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-19-000527

Options or other derivatives

  • See Remarks acquired 329,379 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ryan Jason See Remarks 2019-01-02 Grant or award · Stock Option (Right to Buy) +329,379 329,379 D
Loading xslF345X03/doc4.xml…